PCM
VMD icon

Prelude Capital Management’s Viemed Healthcare VMD Stock Holding History

Prelude Capital Management’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,053
Closed -$108K – 1363
2023
Q2 		$108K Buy
+11,053
New +$112K 0.01% 923
2020
Q4 		– Sell
-200
Closed -$2K – 2043
2020
Q3 		$2K Buy
+200
New +$2.02K ﹤0.01% 1685

Other funds holding VMD

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Prelude Capital Management's VMD Position: Q3 2023 in Review

Prelude Capital Management sold out of Viemed Healthcare (VMD) in Q3 2023, closing a stake of 11,053 shares — an estimated $108K sold.

Prelude Capital Management first reported a position in VMD in Q3 2020 and held it in 2 quarters. The position peaked at $108K in Q2 2023. 112 funds tracked by Wall St. Rank hold VMD as of Q3 2023.

  • Prelude Capital Management reported no remaining Viemed Healthcare position as of Q3 2023 after selling out during the quarter.
  • Prelude Capital Management sold 11,053 Viemed Healthcare shares in Q3 2023, an estimated $108K.
  • Prelude Capital Management first reported a position in Viemed Healthcare in Q3 2020 and held it in 2 quarters.
  • Prelude Capital Management's Viemed Healthcare position peaked at $108K in Q2 2023.
  • 112 funds tracked by Wall St. Rank held Viemed Healthcare as of Q3 2023.

Based on Prelude Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.